Aviva (LON:AV – Get Free Report) had its price target dropped by stock analysts at Citigroup from GBX 687 to GBX 671 in a report released on Tuesday, Marketbeat.com reports. The firm currently has a “neutral” rating on the stock. Citigroup’s price target points to a potential upside of 3.17% from the company’s previous close.
A number of other research analysts have also recently issued reports on AV. Keefe, Bruyette & Woods reaffirmed an “underperform” rating and issued a GBX 650 target price on shares of Aviva in a report on Friday, October 10th. UBS Group reaffirmed a “buy” rating and issued a GBX 750 price objective on shares of Aviva in a research note on Friday, November 7th. Finally, JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a GBX 735 price objective on shares of Aviva in a report on Tuesday, November 11th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of GBX 699.
Check Out Our Latest Stock Report on AV
Aviva Stock Performance
Insider Activity at Aviva
In related news, insider Cheryl Agius acquired 7,284 shares of the company’s stock in a transaction that occurred on Tuesday, October 7th. The stock was purchased at an average price of GBX 683 per share, for a total transaction of £49,749.72. Also, insider Pippa Lambert bought 229 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was purchased at an average cost of GBX 642 per share, with a total value of £1,470.18. Insiders have purchased a total of 33,249 shares of company stock valued at $21,155,518 over the last quarter. Insiders own 0.17% of the company’s stock.
Aviva Company Profile
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.
Featured Articles
- Five stocks we like better than Aviva
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Why Gold Loves Trump as Much as Trump Loves Gold
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- Insider Trading – What You Need to Know
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.
